ARQT - Arcutis Biotherapeutics GAAP EPS of -$1.16 beats by $0.08 revenue of $5.2M beats by $0.58M
2023-08-08 16:15:23 ET
- Arcutis Biotherapeutics press release ( NASDAQ: ARQT ): Q2 GAAP EPS of -$1.16 beats by $0.08 .
- Revenue of $5.2M beats by $0.58M .
- Approximately $270 million in cash, cash equivalents, and marketable securities as of June 30, 2023.
For further details see:
Arcutis Biotherapeutics GAAP EPS of -$1.16 beats by $0.08, revenue of $5.2M beats by $0.58M